CURRENT AFFAIRS

The World Health Organization (WHO) has released global guidelines on the prevention, diagnosis, and treatment of infertility for the first time. Their aim is to make fertility care safer, more affordable, and accessible to all worldwide.

The Regional Artificial Intelligence (AI) Impact Conference 2025 was organized in Shillong, the capital of Meghalaya. This conference is one of the major regional events leading up to the India AI Impact Summit 2026, scheduled for February 2026.

The Union Government recently directed smartphone manufacturers to pre-install the Sanchar Saathi app on all new devices and push it via software updates to existing phones.

The Indian Navy has inducted INS Taragiri (Yard 12653), the fourth Nilgiri-class (Project 17A) frigate and the third P17A vessel constructed by Mazagon Dock Shipbuilders Ltd (MDL).

The Union Minister of Science & Technology visited the Quantum Research Laboratories at IIT Bombay and inaugurated the institute’s Liquid Helium Facility, marking a major advancement in India’s quantum technology, cryogenics, and high-precision materials research ecosystem.

Recently, the Gujarat ATS busted a major terrorist network, with some suspects accused of preparing and using Ricin Poison to carry out terrorist attacks.

The Prime Minister of India recently unveiled Skyroot Aerospace’s first orbital-class launch vehicle, the Vikram-I Rocket, marking a major milestone in India’s emerging private space sector.

The Union Cabinet has cleared a ₹7,280-crore Rare Earth Magnet Scheme to establish India’s first integrated manufacturing ecosystem for Sintered Rare Earth Permanent Magnets (REPMs)—critical components used in EVs, wind turbines, defence systems and advanced electronics.

World Television Day was organized by the Ministry of Information and Broadcasting and Prasar Bharati on November 21, 2025.

Scientists at ICAR–Central Rice Research Institute (CRRI), Cuttack have developed a new indigenous genome-editing platform using TnpB proteins, offering a compact, low-cost and IP-free alternative to globally patented CRISPR-Cas systems.